Cas No.: 651328-78-8
PRODUCT INFORMATION
Description
The Asn-Gly-Arg (NGR) motif-containing peptide is a tumor-targeting ligand that specifically binds to CD13/aminopeptidase N (APN). When conjugated with imaging agents such as 68Ga or 99mTc, the engineered cyclic NGR peptides exhibit rapid tumor uptake and high tumor-to-background contrast in preclinical microPET/SPECT imaging models. This demonstrates their utility for researching precise visualization of CD13-expressing cells.
Molecular Weight
608.69
Purity
> 95%
Formula
C₂₀H₃₆N₁₀O₈S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- MH42 Targeting Peptide (CAT#: OLY-1025-YS-31)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) Targeting Peptide (CAT#: OLY-1025-YS-47)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- 3BP-4089 TFA Targeting Peptide (CAT#: OLY-1025-YS-56)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.